Tetra's Alzheimer's Drug Improves Language, Learning in Fragile X Syndrome

Friday, April 30, 2021
Image
Fragile X Syndrom barcode

An investigational Alzheimer's disease (AD) drug from Tetra Therapeutics appeared to improve language ability and learning in adults with Fragile X Syndrome, according to a new study reported in Nature Medicine.

Read full article

 

Was this page helpful?
Form Approved OMB# 0925-0648 Exp. Date 05/31/2021